Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

ATG7-IN-3

🥰Excellent
Catalog No. T61552Cas No. 2226229-76-9

ATG7-IN-3 (Compound 18) is an effective ATG7 inhibitor (IC₅₀ = 48 nM) capable of suppressing autophagy, suitable for research into gliomas and colorectal cancers.

ATG7-IN-3

ATG7-IN-3

🥰Excellent
Purity: 99.88%
Catalog No. T61552Cas No. 2226229-76-9
ATG7-IN-3 (Compound 18) is an effective ATG7 inhibitor (IC₅₀ = 48 nM) capable of suppressing autophagy, suitable for research into gliomas and colorectal cancers.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$293-In Stock
5 mg$722-In Stock
10 mg$987-In Stock
25 mg$1,460-In Stock
50 mg$1,970-In Stock
100 mg$2,660-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.88%
ee:99.85%
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
ATG7-IN-3 (Compound 18) is an effective ATG7 inhibitor (IC₅₀ = 48 nM) capable of suppressing autophagy, suitable for research into gliomas and colorectal cancers.
Targets&IC50
ATG7:0.048 ± 0.022 μM, LC3B:0.938 ± 0.231 μM, Thioester:0.280 ± 0.051 μM
In vitro
ATG7-IN-3 exhibits inhibitory activity against ATG7 with an IC50 of 0.048 μM [1]. In glioma H4 cells, ATG7-IN-3 inhibits endogenous LC3B puncta formation with an IC50 of 0.938 μM [1]. In SKOV-3 cells, ATG7-IN-3 induces p62 accumulation with an EC50 value of 3.0 μM [1].
In vivo
In the HCT-116 xenograft mouse model, ATG7-IN-3 (150 mg/kg, administered subcutaneously) modulates the autophagic markers LC3B and NBR1 [1].
Chemical Properties
Molecular Weight376.41
FormulaC11H16N6O5S2
Cas No.2226229-76-9
SmilesS(C)C1=NN(C=2C1=C(N)N=CN2)[C@@H]3O[C@H](COS(N)(=O)=O)[C@@H](O)C3
ColorWhite
AppearanceSolid
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 80 mg/mL (212.53 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween-80+45% Saline: 3.3 mg/mL (8.77 mM), Sonication is recommeded.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.6567 mL13.2834 mL26.5668 mL132.8339 mL
5 mM0.5313 mL2.6567 mL5.3134 mL26.5668 mL
10 mM0.2657 mL1.3283 mL2.6567 mL13.2834 mL
20 mM0.1328 mL0.6642 mL1.3283 mL6.6417 mL
50 mM0.0531 mL0.2657 mL0.5313 mL2.6567 mL
100 mM0.0266 mL0.1328 mL0.2657 mL1.3283 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% Saline/PBS/ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
All types of co-solvents required for the protocol, such asDMSO, PEG300/ PEG400, Tween 80, SBE-β-CD, corn oil are available for purchase on the TargetMol website with a simple click.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy ATG7-IN-3 | purchase ATG7-IN-3 | ATG7-IN-3 cost | order ATG7-IN-3 | ATG7-IN-3 chemical structure | ATG7-IN-3 in vivo | ATG7-IN-3 in vitro | ATG7-IN-3 formula | ATG7-IN-3 molecular weight